Taxis 2021-01: Efficacy of a Novel Efflux Pump Inhibitors with Levofloxacin in the Murine Lung and Thigh Infection Models with P. aeruginosa

Project Details

StatusFinished
Effective start/end date27/01/2126/01/22

Funding

  • TAXIS Pharmaceuticals, Inc.: $55,948.86